Shinichiro Yoshitani

Author

Also Known As

S Yoshitani, S. Yoshitani, Shin-Ichiro Yoshitani, Shin-ichiro YOSHITANI, Shin-ichiro Yoshitani, Shinichiro YOSHITANI, Shinichiro Yoshitani, Shin‐ichiro Yoshitani

Publications

601

Citations

H-Index

Concepts

All Affiliations

Kanazawa Medical University

About

Shinichiro Yoshitani is an author at Kanazawa Medical University specializing in medicine, pathology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	496
2	Pathology	3	3	381
3	Gastroenterology	2	2	296
4	Biochemistry	1	1	115
5	Immunology	1	1	276

Shinichiro Yoshitani

Publications

560

Citations

H-Index

Page 1

	Year	Citations
Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Takuji Tanaka, Hideo Kohno, Shinichiro Yoshitani, PubMed InflammationChronic Inflammatory DiseasesSynthetic PparsAnti-inflammatoryMedicine	2001	276
Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet Takuji Tanaka, Masahito Shimizu, Hiroyuki Kohno, Life Sciences BiochemistryMedicineToxicologyPharmacologyZingiber Zerumbet	2001	115
Chemoprevention of azoxymethane-induced rat colon carcinogenesis by dietary capsaicin and rotenone Shinichiro Yoshitani, Takuji Tanaka, Hiroyuki Kohno, International Journal of Oncology Acf DevelopmentPhase IiChemoprevention StrategyMedicineFood Toxicology	2001	85
Troglitazone, a Ligand for Peroxisome Proliferator‐activated Receptor γ Inhibits Chemically‐induced Aberrant Crypt Foci in Rats Hiroyuki Kohno, Shinichiro Yoshitani, Shigeki Takashima, Japanese Journal of Cancer Research	2001	64
Efficacy of Postoperative UFT (Tegafur/Uracil) Plus PSK Therapies in Elderly Patients with Resected Colorectal Cancer Shinichiro Yoshitani, Shigeki Takashima Cancer Biotherapy and Radiopharmaceuticals Surgical OncologyElderly PatientsResected Colorectal CancerColorectal SurgeryGastroenterology	2009	20

Page 1